Your browser doesn't support javascript.
loading
Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells.
Chen, Jiaxuan; Ellert-Miklaszewska, Aleksandra; Garofalo, Stefano; Dey, Arindam K; Tang, Jingjie; Jiang, Yifan; Clément, Flora; Marche, Patrice N; Liu, Xiaoxuan; Kaminska, Bozena; Santoni, Angela; Limatola, Cristina; Rossi, John J; Zhou, Jiehua; Peng, Ling.
Afiliação
  • Chen J; Aix-Marseille Université, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, CNRS, Marseille, France.
  • Ellert-Miklaszewska A; State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, Center of Advanced Pharmaceutics and Biomaterials, China Pharmaceutical University, Nanjing, P. R. China.
  • Garofalo S; Laboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
  • Dey AK; Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.
  • Tang J; Institute for Advanced Biosciences, University Grenoble-Alpes, Inserm U1209, CNRS 5309, La Tronche, France.
  • Jiang Y; Aix-Marseille Université, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, CNRS, Marseille, France.
  • Clément F; Aix-Marseille Université, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, CNRS, Marseille, France.
  • Marche PN; Institute for Advanced Biosciences, University Grenoble-Alpes, Inserm U1209, CNRS 5309, La Tronche, France.
  • Liu X; Institute for Advanced Biosciences, University Grenoble-Alpes, Inserm U1209, CNRS 5309, La Tronche, France.
  • Kaminska B; State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, Center of Advanced Pharmaceutics and Biomaterials, China Pharmaceutical University, Nanjing, P. R. China.
  • Santoni A; Laboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
  • Limatola C; IRCCS Neuromed, Pozzilli, Italy.
  • Rossi JJ; Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.
  • Zhou J; IRCCS Neuromed, Pozzilli, Italy.
  • Peng L; Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope Medical Center, Monrovia, CA, USA.
Nat Protoc ; 16(1): 327-351, 2021 01.
Article em En | MEDLINE | ID: mdl-33277630
ABSTRACT
Using siRNAs to genetically manipulate immune cells is important to both basic immunological studies and therapeutic applications. However, siRNA delivery is challenging because primary immune cells are often sensitive to the delivery materials and generate immune responses. We have recently developed an amphiphilic dendrimer that is able to deliver siRNA to a variety of cells, including primary immune cells. We provide here a protocol for the synthesis of this dendrimer, as well as siRNA delivery to immune cells such as primary T and B cells, natural killer cells, macrophages, and primary microglia. The dendrimer synthesis entails straightforward click coupling followed by an amidation reaction, and the siRNA delivery protocol requires simple mixing of the siRNA and dendrimer in buffer, with subsequent application to the primary immune cells to achieve effective and functional siRNA delivery. This dendrimer-mediated siRNA delivery largely outperforms the standard electroporation technique, opening a new avenue for functional and therapeutic studies of the immune system. The whole protocol encompasses the dendrimer synthesis, which takes 10 days; the primary immune cell preparation, which takes 3-10 d, depending on the tissue source and cell type; the dendrimer-mediated siRNA delivery; and subsequent functional assays, which take an additional 3-6 d.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Linfócitos T / RNA Interferente Pequeno / Interferência de RNA / Dendrímeros Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Linfócitos T / RNA Interferente Pequeno / Interferência de RNA / Dendrímeros Idioma: En Ano de publicação: 2021 Tipo de documento: Article